Lazarides M K, Argyriou C, Antoniou G A, Georgakarakos E, Georgiadis G S
Department of Vascular Surgery, Democritus University Hospital, Alexandroupolis, Greece.
Department of Vascular Surgery, Democritus University Hospital, Alexandroupolis, Greece.
Semin Vasc Surg. 2016 Dec;29(4):192-197. doi: 10.1053/j.semvascsurg.2016.08.003. Epub 2016 Aug 11.
The aim of this study was to evaluate the efficacy of heparin-bonded vascular grafts to offer improved outcomes compared with standard prosthetic grafts in access surgery. A systematic review and meta-analysis was performed and eight studies (seven observational studies and one randomized controlled trial) were included. The pooled 6-month and 1-year primary patency was not significantly different between heparin-bonded arteriovenous (AV) grafts and standard prosthetic AV grafts in seven studies reporting on 1,209 access procedures. The assisted primary patency and secondary patency at 1-year was not significantly different either. Heparin-bonded AV grafts offer no distinct advantage over standard prosthetic AV grafts and their preferential use in access surgery cannot be recommended based on the available evidence.
本研究的目的是评估在血管通路手术中,与标准人工血管移植物相比,肝素结合血管移植物是否能提供更好的治疗效果。我们进行了一项系统评价和荟萃分析,纳入了八项研究(七项观察性研究和一项随机对照试验)。在七项报告了1209例血管通路手术的研究中,肝素结合动静脉(AV)移植物和标准人工AV移植物的6个月和1年累积原发性通畅率无显著差异。1年时的辅助原发性通畅率和继发性通畅率也无显著差异。基于现有证据,肝素结合AV移植物与标准人工AV移植物相比没有明显优势,不建议在血管通路手术中优先使用。